Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean konstantinos papiris[Author] (6 results)?
Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias' treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis.
Pamporis K, Karakasis P, Simantiris S, Sagris M, Bougioukas KI, Fragakis N, Tousoulis D. Pamporis K, et al. Clin Investig Arterioscler. 2024 Mar-Apr;36(2):86-100. doi: 10.1016/j.arteri.2023.11.003. Epub 2023 Nov 30. Clin Investig Arterioscler. 2024. PMID: 38040529 Review. English, Spanish.
Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: A systematic review with Bayesian and frequentist meta-analysis.
Karakasis P, Stalikas N, Patoulias D, Pamporis K, Karagiannidis E, Sagris M, Stachteas P, Bougioukas KI, Anastasiou V, Daios S, Apostolidou-Kiouti F, Giannakoulas G, Vassilikos V, Fragakis N, Giannopoulos G. Karakasis P, et al. Among authors: pamporis k. Trends Cardiovasc Med. 2023 Nov 30:S1050-1738(23)00107-X. doi: 10.1016/j.tcm.2023.11.006. Online ahead of print. Trends Cardiovasc Med. 2023. PMID: 38042441 Review.
Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
Karakasis P, Patoulias D, Pamporis K, Stachteas P, Bougioukas KI, Klisic A, Fragakis N, Rizzo M. Karakasis P, et al. Among authors: pamporis k. Metabolism. 2023 Dec;149:155710. doi: 10.1016/j.metabol.2023.155710. Epub 2023 Oct 16. Metabolism. 2023. PMID: 37852529
Ischemia testing and revascularization in patients with monomorphic ventricular tachycardia: A relic of the past?
Milaras N, Kordalis A, Tsiachris D, Sakalidis A, Ntalakouras I, Pamporis K, Dourvas P, Apostolos A, Sotiriou Z, Arsenos P, Archontakis S, Tsioufis K, Gatzoulis K, Sideris S. Milaras N, et al. Among authors: pamporis k. Curr Probl Cardiol. 2024 Mar;49(3):102358. doi: 10.1016/j.cpcardiol.2023.102358. Epub 2023 Dec 31. Curr Probl Cardiol. 2024. PMID: 38169203 Review.
14 results